Select Publications
Conference Abstracts
2016, 'Children With Empyema Have Exercise Limitation At Least Four Years After Admission- A Pilot Study', in AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, AMER THORACIC SOC, CA, San Francisco, Vol. 193, presented at International Conference of the American-Thoracic-Society (ATS), CA, San Francisco, 13 May 2016 - 18 May 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000390749602289&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'Clinical Effectiveness Of Omalizumab In Severe Allergic Asthma Above The Recommended Dosing Range: The Australian Xolair Registry', in AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, AMER THORACIC SOC, CA, San Francisco, Vol. 193, presented at International Conference of the American-Thoracic-Society (ATS), CA, San Francisco, 13 May 2016 - 18 May 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000390749600407&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'Nutritional Follow-Up Of Congenital Diaphragmatic Hernia Survivors - The Sydney Children's Hospital Experience', in AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, AMER THORACIC SOC, CA, San Francisco, Vol. 193, presented at International Conference of the American-Thoracic-Society (ATS), CA, San Francisco, 13 May 2016 - 18 May 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000390749606349&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'CHILDREN WITH EMPYEMA HAVE EXERCISE LIMITATION AT LEAST FOUR YEARS AFTER ADMISSION- A PILOT STUDY', in RESPIROLOGY, WILEY-BLACKWELL, Vol. 21, pp. 180 - 180, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000373102400403&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'CLINICAL EFFECTIVENESS OF OMALIZUMAB IN SEVERE ALLERGIC ASTHMA ABOVE THE STANDARD DOSING RANGE: THE AUSTRALIAN XOLAIR REGISTRY', in RESPIROLOGY, WILEY-BLACKWELL, Vol. 21, pp. 102 - 102, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000373102400206&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'CLINICAL OUTCOMES OF EARLY PSEUDOMONAS INFECTION IN INFANTS AND YOUNG CHILDREN WITH CYSTIC FIBROSIS', in RESPIROLOGY, WILEY-BLACKWELL, Vol. 21, pp. 167 - 167, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000373102400372&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'NUTRITIONAL FOLLOW-UP OF CONGENITAL DIAPHRAGMATIC HERNIA SURVIVORS - THE SYDNEY CHILDREN'S HOSPITAL EXPERIENCE', in RESPIROLOGY, WILEY-BLACKWELL, Vol. 21, pp. 181 - 181, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000373102400406&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'HUMAN RHINOVIRUS INFECTIONS IN THE CLINICAL EXACERBATIONS OF CHILDREN WITH CYSTIC FIBROSIS', in RESPIROLOGY, WILEY-BLACKWELL, AUSTRALIA, Queensland, Vol. 20, pp. 47 - 47, presented at Thoracic Society Australia New Zealand Australian New Zealand Society Respiratory Science Annual Scientific Meeting 2015, AUSTRALIA, Queensland, 27 March 2015 - 01 April 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000351464400124&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'Absence of seasonal peaks in human rhinovirus and asthma exacerbations in a cohort of children with asthma contrasts to community incidence of disease exacerbations', in Respirology, Wiley, Vol. 20, pp. 54 - 54, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000351464400143&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'SNEEZING LEADS TO WHEEZING: RHINOVIRUS INFECTION IN THE STUDY OF ASTHMA, VIRUSES AND ENVIRONMENT (SAVE) COHORT', in RESPIROLOGY, WILEY-BLACKWELL, Vol. 19, pp. 38 - 38, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000333238100092&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'Asthma Symptoms and Rhinovirus In A Longitudinal Children's Cohort', in JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, MOSBY-ELSEVIER, CA, San Diego, Vol. 133, pp. AB285 - AB285, presented at Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI), CA, San Diego, 28 February 2014 - 04 March 2014, http://dx.doi.org/10.1016/j.jaci.2013.12.1010
,Media
2019, Patients’ avatars being used to test cystic fibrosis drugs, https://newsroom.unsw.edu.au/news/health/patients%E2%80%99-avatars-being-used-test-cystic-fibrosis-drugs
,2019, Mini-organ unlock new understanding about drug and disease, https://www.abc.net.au/radionational/programs/healthreport/
,2019, AVATARS: A revolution in cystic fibrosis treatment. INSPIRE Research Australia, https://issuu.com/researchaustralia/docs/inspire_issue_13_final
,2019, Avatars-a-game-changer-for-children-with-cystic-fibrosis, https://www.schn.health.nsw.gov.au/news/articles/2019/07/avatars-a-game-changer-for-children-with-cystic-fibrosis
,2019, New treatment giving hope to kids with cystic fibrosis, https://www.youtube.com/watch?time_continue=1&v=66eXL0fy1JA&feature=emb_logo
,2018, Avatars take lead role in future CF therapy., https://www.ausdoc.com.au/therapy-update/avatars-take-lead-role-future-cf-therapy
,Preprints
2024, Parent/carers opinions about COVID-19 vaccination for children with chronic lung diseases, http://dx.doi.org/10.22541/au.170666146.66053164/v1
,2023, Hybrid bronzes: mixed-valence organic-inorganic metal oxides as a tunable material platform, http://dx.doi.org/10.26434/chemrxiv-2023-v6h2h
,2023, Quinone-functionalised carbons as new materials for electrochemical carbon dioxide capture, http://dx.doi.org/10.26434/chemrxiv-2023-ls7mc-v2
,2022, Variation in clinical practice guidelines for use of palivizumab in preventing severe respiratory syncytial viral (RSV) disease in high-risk infants, http://dx.doi.org/10.22541/au.166419726.62754781/v1
,2022, Learning to make a difference for chILD: Value creation through network collaboration and team science, http://dx.doi.org/10.22541/au.166740302.29601419/v1
,2022, Variation in clinical practice guidelines for use of palivizumab in preventing severe respiratory syncytial viral (RSV) disease in high-risk infants, http://dx.doi.org/10.22541/au.166419726.62754781/v2
,2021, In silicoand functional characterisation of an ultra-rareCFTRmutation identifies novel lasso motif interactions regulating channel gating, http://dx.doi.org/10.1101/2021.12.12.472297
,2021, Molecular dynamics and theratyping in airway and gut organoids reveal R352Q-CFTR conductance defect, http://dx.doi.org/10.1101/2021.08.11.456003
,2020, Selective, High-Temperature O2 Adsorption in Chemically Reduced, Redox-Active Iron-Pyrazolate Metal–Organic Frameworks, http://dx.doi.org/10.26434/chemrxiv.9922541
,2020, Selective, High-Temperature O2 Adsorption in Chemically Reduced, Redox-Active Iron-Pyrazolate Metal–Organic Frameworks, http://dx.doi.org/10.26434/chemrxiv.9922541.v3
,2020, Selective, High-Temperature O2 Adsorption in Chemically Reduced, Redox-Active Iron-Pyrazolate Metal–Organic Frameworks, http://dx.doi.org/10.26434/chemrxiv.9922541.v4
,2019, Selective, High-Temperature O2 Adsorption in Chemically Reduced, Redox-Active Iron-Pyrazolate Metal–Organic Frameworks, http://dx.doi.org/10.26434/chemrxiv.9922541.v2
,2019, Selective, High-Temperature O2 Adsorption in Chemically Reduced, Redox-Active Iron-Pyrazolate Metal–Organic Frameworks, http://dx.doi.org/10.26434/chemrxiv.9922541.v1
,The Effect of Azithromycin on Structural Lung Disease in Infants with Cystic Fibrosis (COMBAT CF): A Phase 3, Randomised, Double-Blind, Placebo-Controlled Clinical Trial, http://dx.doi.org/10.2139/ssrn.3990938
,Other
2011, Recommendations for managing paediatric empyema thoracis
,